Add BrightSurf on Google Email

Faster approach for starting extended-release naltrexone to treat opioid use disorder shown effective

Starting people with opioid use disorder on extended-release, injectable naltrexone within five to seven days of seeking treatment is more effective than the standard method. This rapid treatment protocol requires closer medical supervision and could make XR-naltrexone a more viable option for treating opioid use disorder.

SourceNIH/National Institute on Drug Abuse·JournalJAMA Network Open·DateMay 8, 2024

Health risks of using cannabis are higher in adolescents than in adults – new study finds

A new study published by the University of Bath found that adolescents are more vulnerable to cannabis use disorder than adults, despite using cannabis less frequently. The study showed that adolescents reported greater negative impacts on daily functioning and symptoms of cannabis use disorder.

SourceUniversity of Bath·JournalEuropean Archives of Psychiatry and Clinical Neuroscience·TypeSurvey·DateMay 5, 2024

Researchers develop rapid test for detecting fentanyl

University of Texas at Dallas researchers have developed a first-of-its-kind, handheld electrochemical sensor that can accurately detect fentanyl in urine within seconds. The device detects even trace amounts of fentanyl with 98% accuracy and could be used to test for the drug in saliva, helping first responders make treatment decisions.

SourceUniversity of Texas at Dallas·JournalACS Applied Materials & Interfaces·TypeExperimental study·DateFeb 5, 2024

Smoking causes brain shrinkage

A recent study published in Biological Psychiatry: Global Open Science found that smoking causes brain shrinkage and increases the risk of age-related cognitive decline and Alzheimer's disease. Quitting smoking can prevent further loss of brain tissue, but stopping does not restore the brain to its original size.

SourceWashU Medicine·JournalBiological Psychiatry·TypeObservational study·DateDec 12, 2023

New process for screening old urine samples reveals previously undetected ‘designer drugs’

Researchers developed a more efficient way to find emerging designer drugs in urine samples, uncovering new synthetic opioids, benzodiazepines, and stimulants that evaded initial screening. The approach can support public health and safety by enabling swift identification of new substances.

SourceUniversity of British Columbia·JournalAnalytical Chemistry·TypeData/statistical analysis·DateNov 15, 2023

How mice choose to eat or to drink

A Stanford University study found that mice resolve conflicts between hunger and thirst through indirect modulation of behavior. The researchers used advanced recording technology to monitor individual neurons in the mouse brain, predicting the animal's choice before it was presented with options.

SourceStanford University·JournalNature·DateNov 8, 2023

Researchers identify brain network that is uniquely activated through injection vs. oral drug use

A study published in Nature Communications reveals that the 'salience network' in the brain is uniquely activated by intravenous drug use, which may be associated with higher addiction rates and faster relief from withdrawal. This finding could lead to the development of new therapies for substance use disorders.

SourceNIH/National Institute on Drug Abuse·JournalNature Communications·DateNov 8, 2023

November issues of American Psychiatric Association journals cover new insights in psychotic disorders, barriers to addiction treatment, bipolar disorder treatment, and more

The latest APA journal issues provide new insights into psychotic disorders, including altered neurodevelopment and early symptoms associated with schizophrenia risk. The issues also highlight racial disparities in diagnosis and predictors of first psychotic episodes. Psychiatric Services features research on barriers to addiction trea...

SourceAmerican Psychiatric Association·JournalAmerican Journal of Psychiatry·DateNov 1, 2023

Treating amphetamine use disorder with stimulants: an encouraging new approach

A new meta-analysis suggests that high-dose prescription psychostimulants like methylphenidate and dextroamphetamine can lower cravings and reduce stimulant use in people with amphetamine-type stimulant use disorder. The study analyzed ten randomized controlled trials and found that effects may increase with higher dosage.

SourceSociety for the Study of Addiction·JournalAddiction·TypeMeta-analysis·DateOct 26, 2023

Most Canadians with arthritis and disabling chronic pain are in excellent mental health

A new study by researchers at the University of Toronto found that most Canadians with arthritis and debilitating chronic pain are free of all psychiatric disorders, including depression. More than half achieve excellent mental health, characterized by daily happiness, high social well-being, and freedom from anxiety and depressive dis...

SourceUniversity of Toronto·JournalPLOS ONE·TypeSurvey·DateOct 13, 2023

Alcohol makes you more likely to approach attractive people but doesn’t make others seem better looking: Study

A new study found that drinking alcohol increases the likelihood of interacting with attractive people, but doesn't change how others are perceived. When intoxicated, men were 1.71 times more likely to choose one of their top-four attractive candidates to interact with in the future.

SourceJournal of Studies on Alcohol and Drugs·JournalJournal of Studies on Alcohol and Drugs·TypeExperimental study·DateAug 30, 2023

New guidance on take-home naloxone for community overdose responders

The Canadian Medical Association Journal published new guidance on take-home naloxone distribution and use by community overdose responders in Canada. The guidance prioritizes preserving life and mitigating harms, and is the result of a collaborative process involving diverse stakeholders from across the country.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeLiterature review·DateAug 28, 2023

Many adults who smoke cigarettes wrongly think that vaping is worse for them, say Hollings researcher and FDA Center for Tobacco Products director

A recent commentary highlights the misconception that vaping is worse for adults who smoke. Experts emphasize the importance of educating adults about relative risks while preventing youth use. For those who can't quit with medications or counseling, transitioning to e-cigarettes may be a less harmful route.

Swap-to-stop’ but let us shop - say vapers

A new study from the University of East Anglia found that most vapers believe a 'Swap-to-Stop' scheme providing free e-cigarettes would have helped them quit smoking. However, some respondents prefer to purchase e-cigarettes commercially due to personal preference for specific products.

SourceUniversity of East Anglia·JournalPerspectives in Public Health·TypeSurvey·DateAug 8, 2023

Cigarette smokers more at risk for tobacco dependence than users of smokeless tobacco or multiple tobacco products

A Mount Sinai study published in Nicotine & Tobacco Research found that cigarette smokers are more likely to experience tobacco dependence compared to those who use smokeless tobacco or multiple products. The researchers identified three distinct groups of tobacco users and suggested tailored cessation programs for each group.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNicotine & Tobacco Research·DateJul 26, 2023

Earlier transfer to specialized care associated with better outcomes for neonates with opioid withdrawal syndrome (NOWS)

A new study shows that earlier transfer to specialized care is associated with better outcomes for infants with NOWS, including shorter hospital stays and less exposure to medication. The study found that nonpharmacologic interventions, such as swaddling and pacifier use, are critical to clinical outcomes.

SourceKessler Foundation·JournalHospital Pediatrics·TypeData/statistical analysis·DateJul 26, 2023